Drug Information: Cerebrolysin
Product Nature:
Cerebrolysin is a prescription neuroprotective agent. Its active ingredients are a specific mixture of low-molecular-weight peptides and amino acids, derived from the standardized enzymatic hydrolysis of porcine brain tissue.
Approved Medical Uses (vary by country/region):
-
Treatment of acute ischemic stroke (cerebral infarction).
-
Treatment of vascular dementia and dementia syndromes such as Alzheimer’s disease.
-
As an adjunctive therapy following brain trauma or brain surgery.
-
For developmental delays in children (in some regions).
Route of Administration and Dosage Form:
This product is a sterile injection. It must be administered via intravenous infusion or intramuscular injection under the supervision of a healthcare professional.
Important Safety Warnings:
-
This product is a prescription drug. A comprehensive evaluation by a physician is mandatory prior to use, and contraindications (such as severe renal insufficiency, epilepsy, etc.) must be ruled out.
-
It may cause adverse reactions, including injection site reactions, fever, dizziness, allergies, etc.
-
It is strictly prohibited to purchase, self-administer, or alter the dosage and administration method without authorization.
Reviews
There are no reviews yet.